statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sino Biopharmaceutical (OTCMKTS:SBMFF  Get Free Report) and Unity Biotechnology (NASDAQ:UBX  Get Free Report) are both medical companies, but which is the better business? We will...

Unity Biotechnology (NASDAQ:UBX) versus Sino Biopharmaceutical (OTCMKTS:SBMFF) Financial Review

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Unity Biotechnology announces new research on potential of Senolytics

SOUTH SAN FRANCISCO, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. ( UNITY ) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases...

New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss

Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi, and Daohong Zhou on March 30, 2009 and is headquartered in South San Francisco, CA.

Unity Biotechnology Inc

Watchers	3,830
52-Wk Low	$1.46
52-Wk High	$3.82

Volume	39,631.00
52-Wk High	$3.82
52-Wk Low	$1.46

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.57	--	--	N/A
Q4'23	-$0.61	-$0.28	53.83%	BEAT
Q3'23	-$0.86	-$1.05	-22.30%	MISSED
Q2'23	-$0.80	-$0.85	-6.10%	MISSED
Q1'23	-$1.08	-$0.76	29.58%	BEAT

UBX Unity Biotechnology Inc

About

Feed

News

Sentiment

Earnings

Fundamentals